NCT03197259
- Conditions
- Chromosome 17 deletion, Chronic Disease, Chronic Lymphocytic Leukemia, +16 more
- Locations
-
- Dokuz Eylum Medical Favulty Izmir, Turkey (Türkiye)
Clinical trial condition
Chronic Lymphocytic Leukemia
Explore clinical trials studying Chronic Lymphocytic Leukemia. Study availability and eligibility vary by location and protocol.
532 public trials
93 recruiting studies
Chronic Lymphocytic Leukemia trial results
NCT04771507
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
- Locations
-
- St Olavs Hospital Trondheim, Norway
- Falu lasarett Falun, Dalarna County, Sweden
- Gävle Hospital Gävle, Gävleborg County, Sweden
- Skåne University Hospital Lund, Skåne County, Sweden
NCT03980002
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College Tianjin, Tianjin Municipality, China
NCT07796373
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT07463976
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +17 more
- Locations
-
- The Royal Wolverhampton NHS Trust Wolverhampton, United Kingdom
Not yet recruiting
Study of Zanubrutinib in Older Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL)
NCT07739459
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
- Locations
-
- Chu Lyon-Sud Lyon, Pierre Bénite, France
- Ch Victor Dupouy Argenteuil, France
- Ch D'Avignon - Hopital Henri Duffaut Avignon, France
- Ch de La Cote Basque Bayonne, France
Not yet recruiting
Study on Treatment Outcome Patterns for Patients With CLL After Discontinuation of BTK Inhibitors
NCT07526597
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
- Locations
-
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States
Not yet recruiting
Epcoritamab Plus Venetoclax Plus Ibrutinib in Patients With Chronic Lymphocytic Leukemia With TP53 Alterations
NCT07738887
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
- Locations
-
- Institut Jules Bordet Brussels, Belgium
- Universitair Ziekenhuis Gent Ghent, Belgium
- HELORA - Hôpital de La Louvière Site Jolimont La Louvière, Belgium
- U.Z. LEUVEN - Campus GASTHUISBERG Leuven, Belgium
Not yet recruiting
Atrial Fibrillation Among Patients With Hematologic Malignancies on Tyrosine Kinase Inhibitor Therapy
NCT07711327
- Conditions
- Arrhythmias, Cardiac, Atrial Fibrillation, Atrial Fibrillation (AF), +35 more
- Locations
-
- City of Hope Duarte, California, United States
- UC San Diego Health San Diego, California, United States
- Stanford Health Care Stanford, California, United States
Not yet recruiting
Nemtabrutinib With Venetoclax and Obinutuzumab in Patients With Chronic Lymphocytic Leukemia
NCT07690891
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
- Locations
-
- Froedtert & the Medical College of Wisconsin Milwaukee, Wisconsin, United States